Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance "GASNIV"

Completed

Phase 2 Results N/A

Summary of Purpose

To find out if spatial neglect following stroke and brain injury can be reduced using guanfacine, a drug that was shown to improve neglect in two stroke patients in a previous pilot study (Malhotra et al, 2006). In this trial, the effects of guanfacine will be examined in a larger number of patients, and there will also be a systematic assessment of whether the drug is only effective in patients with particular...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 June 2015.

1 Apr 2010 7 Aug 2009 1 Aug 2014 1 Aug 2014 1 Jun 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Crossover Assignment

Contacts

Not available